These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27562635)
1. Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant. Ruan J; Duan Y; Li F; Wang Z Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):71-78. PubMed ID: 27562635 [TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effect of a human papillomavirus DNA vaccine harboring E6E7 fusion gene and vascular endothelial growth factor receptor 2 gene. Gao J; Fan L; Ma W; Xiao H Microbiol Immunol; 2016 Sep; 60(9):626-33. PubMed ID: 27515281 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model. Gao FS; Zhan YT; Wang XD; Zhang C Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):353-357. PubMed ID: 30111221 [TBL] [Abstract][Full Text] [Related]
4. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats. Zhang S; Zhang H; Shi H; Yu X; Kong W; Li W Hum Immunol; 2008; 69(4-5):250-8. PubMed ID: 18486759 [TBL] [Abstract][Full Text] [Related]
5. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma. Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791 [TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis. Yin X; Wang W; Zhu X; Wang Y; Wu S; Wang Z; Wang L; Du Z; Gao J; Yu J Biochem Biophys Res Commun; 2015 Sep; 465(2):239-44. PubMed ID: 26253468 [TBL] [Abstract][Full Text] [Related]
7. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor. Zhai Y; Zhou Y; Li X; Feng G Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258 [TBL] [Abstract][Full Text] [Related]
8. [Enhanced inhibitory effect of MUC1 gene vaccine on breast cancer growth by GM-CSF]. Yuan SF; Li KZ; Wang L; Yan Z; Han W; Zhang YQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):737-40. PubMed ID: 15555449 [TBL] [Abstract][Full Text] [Related]
9. MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model. Liu C; Xie Y; Sun B; Geng F; Zhang F; Guo Q; Wu H; Yu B; Wu J; Yu X; Kong W; Zhang H Scand J Immunol; 2018 Feb; 87(2):63-72. PubMed ID: 29193199 [TBL] [Abstract][Full Text] [Related]
10. [Construction and expression of eukaryotic coexpression plasmid containing human MUC1 gene and GM-CSF gene]. Yuan SF; Shi CH; Yan W; Yao Q; Li NL; Wang T; Wang L; Zhang YQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):18-20, 24. PubMed ID: 17210098 [TBL] [Abstract][Full Text] [Related]
11. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227 [TBL] [Abstract][Full Text] [Related]
12. [Effects of cell-mediated immunity induced by intramuscular chitosan-pJME/ GM-CSF nano-DNA vaccine in BAlb/c mice]. Zhai YZ; Zhou Y; Ma L; Feng GH Bing Du Xue Bao; 2014 Jul; 30(4):423-8. PubMed ID: 25272598 [TBL] [Abstract][Full Text] [Related]
13. MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model. Zhang H; Liu C; Zhang F; Geng F; Xia Q; Lu Z; Xu P; Xie Y; Wu H; Yu B; Wu J; Yu X; Kong W Vaccine; 2016 May; 34(24):2648-55. PubMed ID: 27113167 [TBL] [Abstract][Full Text] [Related]
14. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice. Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840 [TBL] [Abstract][Full Text] [Related]
15. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection. Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256 [TBL] [Abstract][Full Text] [Related]
17. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF. Yuan S; Shi C; Han W; Ling R; Li N; Wang T Eur J Cancer Prev; 2009 Sep; 18(5):416-23. PubMed ID: 19550341 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model. Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367 [TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670 [TBL] [Abstract][Full Text] [Related]
20. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model. Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]